News releases | Medicago

Medicago

Menu
  • Our company
    Our company
    • Our history
    • Our mission and values
    • Our commitment to ethics
    • Our pandemic response
    • Our leadership team
    • Our locations
    • Our partners
  • Our science
    Our science
    • Your health
    • Our R&D pipeline
    • Our clinical trials
    • Our vaccine candidates
    • Our therapeutic antibody research
  • Our technologies
    Our technologies
    • Plant-based technology
    • Our technology illustrated
    • Virus-like particles
  • Our vaccines
    Our vaccines
    • Covifenz
    • Reporting side effects
  • Media
  • Careers
  • Culture
  • FAQ
  • Contact
  • fr
  • News releases

News releases

  • All
  • Antibodies 1
  • Corpo 8
  • Vaccine 19
  • Clinical trials 7
  • COVID-19 17
    • Vaccine
    • Clinical trials
    • COVID-19
    October 1, 2021

    Medicago to launch clinical trials for COVID-19 vaccine candidate with GSK’s pandemic adjuvant in Japan

    Press Release Medicago
    Read more
    • Vaccine
    • Clinical trials
    • COVID-19
    May 18, 2021

    Medicago and GSK announce positive interim phase 2 results for adjuvanted COVID-19 vaccine candidate

    Press Release Medicago
    Read more
    • Vaccine
    • Clinical trials
    • COVID-19
    March 16, 2021

    Medicago and GSK start phase 3 trial of adjuvanted COVID-19 vaccine candidate

    Press Release Medicago
    Read more
    • Vaccine
    • Clinical trials
    • COVID-19
    November 12, 2020

    Medicago and GSK announce start of phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate

    Press release Medicago 2020
    Read more
    • Vaccine
    • Clinical trials
    • COVID-19
    November 10, 2020

    Medicago announces positive phase 1 results for its COVID-19 vaccine candidate

    Press release Medicago 2020
    Read more
    • Vaccine
    • Clinical trials
    • COVID-19
    July 14, 2020

    Medicago begins phase 1 clinical trials for its COVID-19 vaccine candidate

    Press release Medicago 2020
    Read more
    • Vaccine
    • Clinical trials
    September 26, 2017

    Medicago announces Phase 3 study of VLP quadrivalent influenza vaccine

    Press release Medicago 2015-2017
    Read more
Medicago
  • Media
  • Careers
  • Culture
  • FAQ
  • Contact
  • Our company
    Our company
    • Our history
    • Our mission and values
    • Our commitment to ethics
    • Our pandemic response
    • Our leadership team
    • Our locations
    • Our partners
  • Our science
    Our science
    • Your health
    • Our R&D pipeline
    • Our clinical trials
    • Our vaccine candidates
    • Our therapeutic antibody research
  • Our technologies
    Our technologies
    • Plant-based technology
    • Our technology illustrated
    • Virus-like particles
  • Our vaccines
    Our vaccines
    • Covifenz
    • Reporting side effects
  • Legal
  • Privacy
  • Community guideline
  • Cookie policy
© Medicago Inc, 2022

This website uses cookies. Find out more

You are leaving a Medicago website

Medicago does not review or control the content of non-Medicago websites, and this link does not constitute an endorsement by Medicago of that site’s content.